Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients
ObjectivesHyperkalemia most commonly develops in chronic kidney disease (CKD) or heart failure (HF) patients. Sodium zirconium cyclosilicate (SZC) is a new selective potassium (K+) binder for treating hyperkalemia. The aim of this study was to evaluate the cost-effectiveness of SZC vs. usual care fo...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-12-01
|
| Series: | Frontiers in Public Health |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1196789/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|